Baxter Deutschland GmbH, based in Unterschleissheim, is a significant player in the pharmaceutical industry, acting as a commission agent for Baxter Healthcare S.A. and as a manufacturing entity. Its portfolio includes infusion solutions, nutrition therapy products, oncology, anesthesia, and drug delivery systems. Since August 2023, the company has operated a plant in Bielefeld for the production of oncological active ingredients, which are distributed globally. In 2024, the "Renal" dialysis segment was sold to the Vantive Group to focus on strategic realignment.
Herstellung, Kauf, Verkauf, Vertrieb, Einfuhr, Ausfuhr und Handel in pharmazeutischen Artikeln, Chemikalien, Diagnostika, Prothesen, Implantaten, Krankenhausbedarfsartikeln, Ernährungsspezialprodukten sowie Geräten für medizinische, technische und wissenschaftliche Einrichtungen nebst allen damit im direkten und indirektem Zusammenhang stehenden Produkten, einschließlich der Entwicklung und Weitergabe des entsprechenden Wissens; ferner Schulungen und Beratungen.
Converted using the official Destatis and Eurostat correspondence tables; ISIC Rev. 4 is the United Nations' international industry classification.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) München Local Court, HRB 42976 (as of 26 October 2026)
| Name | Type | City |
|---|---|---|
| Sascha Hanselmann | Geschäftsführer(in) | Zolling |
Source: German Commercial Register (Handelsregister) München Local Court, HRB 42976 (as of 26 October 2026)
| Date | Event Type | Event |
|---|---|---|
| 16.11.2023 | Gesellschaftsvertrag amended | Gesellschaftsvertrag |
| 06.10.2009 | Registered Seat Change | Baxter Deutschland GmbH |
| 10.02.2009 | Business Address Registered | Edisonstr. 4, 85716 Unterschleißheim |
| Date | Type | Change | Total Capital |
|---|---|---|---|
| 03.01.2002 | Share Capital Set | — | 10.740.000 € |
| Date | Contract | Value |
|---|---|---|
| 22.10.2026 | Supplier · PBMG eG | — |
| 13.3.2026 | Supplier · PBMG eG | — |
| 17.1.2025 | System zur patientenindividuellen Verblisterung Supplier · Kliniken der Stadt Köln gGmbH | 449.093 € |
Source: German Commercial Register (Handelsregister) München Local Court, HRB 42976 (as of 26 October 2026)
| Year | Revenue | Profit | Balance | Employees |
|---|---|---|---|---|
| 2024 | €277,897,000 | €38,076,000 | €733,834,000 | 258 |
| 2023 | €133,877,000 | €5,907,000 | €660,087,000 | 325 |
| 2022 | €114,536,000 | €10,675,000 | €205,802,000 | 333 |
| 2021 | €118,737,000 | €6,799,000 | €183,771,000 | 346 |
| 2020 | €140,169,000 | €25,481,000 | €206,007,000 | 340 |
| 2019 | €125,233,875 | €5,842,918 | €179,262,000 | 348 |
| 2018 | €124,777,542 | €0 | €168,128,000 | 364 |
| 2017 | €125,931,972 | €7,699,066 | €151,440,964 | 387 |
| 2016 | €146,156,814 | €0 | €165,759,861 | 447 |
| 2015 | €89,074,653 | €0 | €135,911,982 | 352 |
Sign in to download data
Source: German Commercial Register (Handelsregister) München Local Court, HRB 42976 (as of 26 October 2026)
Dr. Beckmann Group GmbH
Frankfurt am Main · Herstellung von pharmazeutischen Grundstoffen
Amapharm GmbH
Neunkirchen · Herstellung von pharmazeutischen Spezialitäten und sonstigen pharmazeutischen Erzeugnissen
Medtronic Gesellschaft mit beschränkter Haftung
Meerbusch · Großhandel mit medizinischen und orthopädischen Artikeln, Dental- und Laborbedarf
| Cost type | Amount | Share |
|---|---|---|
| Personnel Costs | €34,112,000 | 19.3% |
| Material Costs | €79,342,000 | 44.9% |
| Depreciation | €35,984,000 | 20.4% |
| Interest & Similar | €27,272,000 | 15.4% |
